Jubilant Pharmova announces voluntary prepayment of US$ 75 million term loan
News

Jubilant Pharmova announces voluntary prepayment of US$ 75 million term loan

As on 31st March 2024, Jubilant Pharmova Limited reported Gross Debt at Rs. 3,414 crore

  • By IPP Bureau | June 15, 2024

Jubilant Pharma Holdings Inc., USA (JPH), a wholly owned subsidiary of Jubilant Pharma Limited (JPL) has issued a notice to its lenders to voluntary prepay US$ 75 million term loan, equivalent to Rs. 626 crore by the next interest payment date i.e. 24th June 2024. JPL is a wholly owned subsidiary of Jubilant Pharmova Limited.

 As on 31st March 2024, Jubilant Pharmova Limited reported Gross Debt at Rs. 3,414 crore and Net Debt at Rs. 2,457 crore on a consolidated basis.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International